Read Larry Connors' blog – Short Term Trading Strategies
Mr. Bergson has been in the management consulting and software services industries for 25 years with a strong focus on life sciences. Before joining Virtify, he was an independent consultant for a global management consulting firm where he led the design and commercialization of a life sciences business process outsourcing practice. Prior to that, he was a vice president at Capgemini in its Global Life Sciences practice. Before joining Capgemini, Mr. Bergson was the North American CEO at ARINSO International, a provider of management consulting services and HR business process outsourcing for Fortune 250 corporations. Prior to ARINSO, Mr. Bergson was a principal partner in the Ernst & Young Global Life Sciences practice with responsibilities for core service areas across the global practice. For more details visit the company section at www.virtify.com/company-management-team.htm#stephen_bergson
"I am extremely excited about the depth and breadth of our solutions and the benefits that we are extending to our customers," said Mr. Bergson. "Virtify has built a robust software platform that is purpose-built for the unique regulatory content management and compliance requirements of life sciences companies and has truly raised the bar for success."
Mr. Bergson has already begun to build out his sales and marketing team at Virtify with the hiring of Dwight Galler as senior director of marketing and Michael Engro as regional director of sales.
Mr. Galler will lead the company's corporate and product marketing functions. He brings over 20 years of experience in technology and B2B environments, most recently as vice president of marketing with Bridgeline Software and GMI, of Seattle, Washington. Previously, Mr. Galler was vice president of marketing for enterprise Web survey firm Perseus (now Vovici), where he helped establish the company as the industry leader in the new category of "Enterprise Feedback Management" solutions. Prior to Perseus, Mr. Galler was director of marketing communications for Netegrity, Inc., where he built and led the company's outbound marketing, corporate identity, and lead generation efforts for close to five years.
Mr. Engro has over 20 plus years of sales and business development experience in technology and B2B environments with the past 10 years focused exclusively in the life sciences Industry. For the last four years, Mr. Engro held a sales management position with Capgemini US LLC where he was responsible for major account management and development in both the pharmaceutical and bio-technology industries. Prior to Capgemini US LLC, Mr. Engro was director of sales and marketing for First Consulting Group (now CSC), director of sales and national accounts for CDI and director of sales for ASI.
Building on Growth
As global health and regulatory authorities continue to push for tighter controls and electronic standards, many life sciences organizations find themselves challenged due to outdated processes that are fragmented and paper-based. To enable accurate and timely compliance customers are demanding new technologies and systems that are modeled on best-practices and easily configurable to adapt to changing regulatory requirements.
Virtify has emerged as an innovator and technology leader in Enterprise Content Compliance for life sciences. The company has quietly built a strong reputation and following in the life sciences industry where R&D, clinical trial and submissions activities have become increasingly regulated. Virtify's easy-to-use Virtx software suite is the industry's only solution to provide a secure, collaborative web-based environment for managing regulated content throughout the entire product continuum -- from pre-clinical through product registration to commercialization. The Virtify product suite is highly modular and built to comply with a variety of different global standards and mandates surrounding clinical trial transparency, eCTD, SPL/PLR/PIM, and submissions planning and tracking. Its open architecture is standards-based and designed to leverage a company's existing infrastructure including standard security systems, databases and legacy document management systems.
"With Steve and his team, we've added a strong combination of strategic consulting, solution development and go-to-market leadership skills that will enable us to fully leverage this opportunity and help take the company to the next level. Steve is a great addition to the Virtify team," said Dr. Satish Tadikonda, president and founder of Virtify Inc.
About Virtify
Virtify is the market leader in Enterprise Content Compliance solutions for Life Sciences. Organizations rely on Virtify solutions to reduce time-to-market, risk, and costs by managing and automating the complex regulatory compliance and content exchange requirements throughout the product life cycle. Virtify's easy-to-use Virtx software suite is the industry's only solution to provide a secure, collaborative web-based environment for managing regulated content throughout the entire continuum -- from pre-clinical through product registration to commercialization. The company plays a leadership role in the development of global regulatory standards and is an active participant in a variety of standards committees. Virtify's software products combined with comprehensive professional services and deep domain expertise enhance quality and compliance for some of the world's leading life sciences companies.
Virtify is headquartered in Cambridge, Massachusetts (USA) with facilities in Europe and Asia. For more information, visit www.virtify.com
SOURCE Virtify, Inc.
http://www.virtify.com
More News:
Market Updates |
Stock Alerts |
All Trading News |
Stock Index
About TradingMarkets | Contact | Advertise | Careers | Link to Us | Site Map | Help | Terms & Conditions | Privacy Policy | Return Policy | Testimonials | Feedback
The Connors Group, Inc. ("Company") is not an investment advisory service, nor a registered investment advisor or broker-dealer and does not purport to tell or suggest which securities or currencies customers should buy or sell for themselves. The analysts and employees or affiliates of Company may hold positions in the stocks, currencies or industries discussed here. You understand and acknowledge that there is a very high degree of risk involved in trading securities and/or currencies. The Company, the authors, the publisher, and all affiliates of Company assume no responsibility or liability for your trading and investment results. Factual statements on the Company's website, or in its publications, are made as of the date stated and are subject to change without notice.
It should not be assumed that the methods, techniques, or indicators presented in these products will be profitable or that they will not result in losses. Past results of any individual trader or trading system published by Company are not indicative of future returns by that trader or system, and are not indicative of future returns which be realized by you. In addition, the indicators, strategies, columns, articles and all other features of Company's products (collectively, the "Information") are provided for informational and educational purposes only and should not be construed as investment advice. Examples presented on Company's website are for educational purposes only. Such set-ups are not solicitations of any order to buy or sell. Accordingly, you should not rely solely on the Information in making any investment. Rather, you should use the Information only as a starting point for doing additional independent research in order to allow you to form your own opinion regarding investments. You should always check with your licensed financial advisor and tax advisor to determine the suitability of any investment.
HYPOTHETICAL OR SIMULATED PERFORMANCE RESULTS HAVE CERTAIN INHERENT LIMITATIONS. UNLIKE AN ACTUAL PERFORMANCE RECORD, SIMULATED RESULTS DO NOT REPRESENT ACTUAL TRADING AND MAY NOT BE IMPACTED BY BROKERAGE AND OTHER SLIPPAGE FEES. ALSO, SINCE THE TRADES HAVE NOT ACTUALLY BEEN EXECUTED, THE RESULTS MAY HAVE UNDER- OR OVER-COMPENSATED FOR THE IMPACT, IF ANY, OF CERTAIN MARKET FACTORS, SUCH AS LACK OF LIQUIDITY. SIMULATED TRADING PROGRAMS IN GENERAL ARE ALSO SUBJECT TO THE FACT THAT THEY ARE DESIGNED WITH THE BENEFIT OF HINDSIGHT. NO REPRESENTATION IS BEING MADE THAT ANY ACCOUNT WILL OR IS LIKELY TO ACHIEVE PROFITS OR LOSSES SIMILAR TO THOSE SHOWN.
The Connors Group, Inc.
10 Exchange Place, Suite 1800
Jersey City, NJ 07302
© Copyright 2009 The Connors Group, Inc.
